FMP
Merrimack Pharmaceuticals, Inc.
MACK
NASDAQ
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
14.73 USD
0.02 (0.136%)
About
ceo
Mr. Gary L. Crocker M.B.A.
sector
Healthcare
industry
Biotechnology
website
https://www.merrimack.com
exchange
NASDAQ
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
CIK
0001274792
ISIN
US5903282094
CUSIP
590328209
Address
One Broadway
Phone
617 720 8606
Country
US
Employee
0
IPO Date
Mar 29, 2012
Summary
CIK
0001274792
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
590328209
ISIN
US5903282094
Country
US
Price
14.73
Beta
1.43
Volume Avg.
131.56k
Market Cap
214.05M
Shares
-
52-Week
11.53-15.89
DCF
0.42
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-184.12
P/B
-
Website
https://www.merrimack.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MACK News
It looks like there's no news available.
